| no |
title |
author |
magazine |
year |
volume |
issue |
page(s) |
type |
| 1 |
Adjuvant chemotherapy in endometrial cancer
|
Gómez-Raposo, César
|
|
|
85 |
3 |
p. 477-486
|
article
|
| 2 |
A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
|
Li, Xiaoyu
|
|
|
85 |
3 |
p. 593-604
|
article
|
| 3 |
A Phase I dose-escalation, pharmacokinetics and food-effect study of oral donafenib in patients with advanced solid tumours
|
Li, Xiaoyu
|
|
|
85 |
3 |
p. 593-604
|
article
|
| 4 |
A randomized, double-blind, single-dose study to evaluate the biosimilarity of QL1101 with bevacizumab in healthy male subjects
|
Liu, Ya-nan
|
|
|
85 |
3 |
p. 555-562
|
article
|
| 5 |
A retrospective study of the correlation of in vitro chemosensitivity using ATP-TCA with patient clinical outcomes in acute myeloid leukemia
|
Xia, Fan
|
|
|
85 |
3 |
p. 509-515
|
article
|
| 6 |
Blood mRNA expression of REV3L and TYMS as potential predictive biomarkers from platinum-based chemotherapy plus pemetrexed in non-small cell lung cancer patients
|
Agulló-Ortuño, M. Teresa
|
|
|
85 |
3 |
p. 525-535
|
article
|
| 7 |
Cardioprotective effects of dapsone against doxorubicin-induced cardiotoxicity in rats
|
Sheibani, Mohammad
|
|
|
85 |
3 |
p. 563-571
|
article
|
| 8 |
Characterization of infections and hypogammaglobulinemia treated with the combination of pertuzumab and trastuzumab
|
Mortimer, Joanne E.
|
|
|
85 |
3 |
p. 501-507
|
article
|
| 9 |
Evaluation of gefitinib systemic exposure in EGFR-mutated non-small cell lung cancer patients with gefitinib-induced severe hepatotoxicity
|
Kawamura, Takahisa
|
|
|
85 |
3 |
p. 605-614
|
article
|
| 10 |
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
|
Babiker, Hani M.
|
|
|
85 |
3 |
p. 621-626
|
article
|
| 11 |
Evaluation of the bioequivalence and food effect on the bioavailability of CC-486 (oral azacitidine) tablets in adult patients with cancer
|
Babiker, Hani M.
|
|
|
85 |
3 |
p. 621-626
|
article
|
| 12 |
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance
|
White-Koning, Melanie
|
|
|
85 |
3 |
p. 585-592
|
article
|
| 13 |
Formulae recently proposed to estimate renal glomerular filtration rate improve the prediction of carboplatin clearance
|
White-Koning, Melanie
|
|
|
85 |
3 |
p. 585-592
|
article
|
| 14 |
Interstitial lung disease in advanced pancreatic ductal adenocarcinoma patients treated with gemcitabine and nab-paclitaxel combination therapy: a retrospective analysis
|
Irie, Hiroki
|
|
|
85 |
3 |
p. 517-523
|
article
|
| 15 |
Population pharmacokinetic modeling of PF-06439535 (a bevacizumab biosimilar) and reference bevacizumab (Avastin®) in patients with advanced non-squamous non-small cell lung cancer
|
Li, Cheryl S. W.
|
|
|
85 |
3 |
p. 487-499
|
article
|
| 16 |
Preoperative chemoradiotherapy using gemcitabine for pancreatic ductal adenocarcinoma in patients with impaired renal function
|
Tomimaru, Yoshito
|
|
|
85 |
3 |
p. 537-545
|
article
|
| 17 |
Relationship between vemurafenib plasma concentrations and survival outcomes in patients with advanced melanoma
|
Kichenadasse, Ganessan
|
|
|
85 |
3 |
p. 615-620
|
article
|
| 18 |
The influence of single-nucleotide polymorphisms on overall survival and toxicity in cabazitaxel-treated patients with metastatic castration-resistant prostate cancer
|
Belderbos, Bodine P. S.
|
|
|
85 |
3 |
p. 547-553
|
article
|
| 19 |
The use of Trichomonas vaginalis purine nucleoside phosphorylase to activate fludarabine in the treatment of solid tumors
|
Parker, William B.
|
|
|
85 |
3 |
p. 573-583
|
article
|
Journal description